Latest Insider Transactions at Royalty Pharma PLC (RPRX)
This section provides a real-time view of insider transactions for Royalty Pharma PLC (RPRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Royalty Pharma plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Royalty Pharma plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
13,974
-3.15%
|
$558,960
$40.77 P/Share
|
|
May 26
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
86,026
-16.23%
|
$3,441,040
$40.21 P/Share
|
|
May 23
2022
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100,000
-15.87%
|
$4,000,000
$40.27 P/Share
|
|
May 20
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
123,696
-21.5%
|
$4,824,144
$39.28 P/Share
|
|
May 19
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
26,304
-4.37%
|
$1,052,160
$40.09 P/Share
|
|
May 19
2022
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
75,000
-6.41%
|
$3,000,000
$40.44 P/Share
|
|
May 16
2022
|
Marshall Urist EVP, Research & Investments |
SELL
Open market or private sale
|
Direct |
23,333
-33.33%
|
$909,987
$39.85 P/Share
|
|
May 11
2022
|
Marshall Urist EVP, Research & Investments |
BUY
Conversion of derivative security
|
Direct |
70,000
+50.0%
|
-
|
|
Apr 14
2022
|
Legorreta Pablo G. CEO, Chairman of the Board |
SELL
Other acquisition or disposition
|
Direct |
350,000
-84.58%
|
-
|
|
Apr 14
2022
|
Legorreta Pablo G. CEO, Chairman of the Board |
SELL
Other acquisition or disposition
|
Indirect |
462,031
-100.0%
|
-
|
|
Mar 31
2022
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
964
+3.76%
|
$36,632
$38.87 P/Share
|
|
Mar 31
2022
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
964
+4.85%
|
$36,632
$38.87 P/Share
|
|
Mar 29
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
60,000
-9.07%
|
$2,280,000
$38.59 P/Share
|
|
Mar 21
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
39,867
-100.0%
|
$1,554,813
$39.05 P/Share
|
|
Mar 18
2022
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
129,222
-56.37%
|
$5,039,658
$39.51 P/Share
|
|
Mar 17
2022
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,836,488
-83.8%
|
-
|
|
Mar 17
2022
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
68,964
+4.82%
|
-
|
|
Feb 24
2022
|
Henry A Fernandez Director |
BUY
Open market or private purchase
|
Indirect |
32,500
+35.83%
|
$1,202,500
$37.49 P/Share
|
|
Dec 31
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
958
+3.88%
|
$37,362
$39.11 P/Share
|
|
Dec 31
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
958
+5.07%
|
$37,362
$39.11 P/Share
|
|
Dec 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
75,000
-11.23%
|
$3,000,000
$40.0 P/Share
|
|
Dec 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
109,448
-6.97%
|
$4,377,920
$40.21 P/Share
|
|
Dec 28
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,265,552
-34.97%
|
-
|
|
Dec 28
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
45,350
+3.22%
|
-
|
|
Nov 17
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
139,389
-5.65%
|
$5,854,338
$42.34 P/Share
|
|
Nov 17
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
62,435
-9.12%
|
$2,622,270
$42.39 P/Share
|
|
Nov 17
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
84,148
-11.78%
|
$3,534,216
$42.39 P/Share
|
|
Nov 16
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
1,861,351
-32.64%
|
-
|
|
Nov 16
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
12,565
-1.8%
|
$527,730
$42.01 P/Share
|
|
Nov 16
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
66,012
+4.41%
|
-
|
|
Nov 16
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
165,852
-8.62%
|
$6,965,784
$42.55 P/Share
|
|
Sep 30
2021
|
Bonnie L Bassler Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+4.17%
|
$36,704
$37.8 P/Share
|
|
Sep 30
2021
|
Henry A Fernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
992
+5.52%
|
$36,704
$37.8 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Other acquisition or disposition
|
Indirect |
936,427
-14.1%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Indirect |
63,777
-1.56%
|
$2,295,972
$36.43 P/Share
|
|
Sep 29
2021
|
Rory B Riggs Director |
BUY
Other acquisition or disposition
|
Direct |
16,274
+0.86%
|
-
|
|
Sep 29
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
24,648
-3.85%
|
$887,328
$36.5 P/Share
|
|
Sep 28
2021
|
Rory B Riggs Director |
SELL
Open market or private sale
|
Direct |
40,000
-5.88%
|
$1,440,000
$36.75 P/Share
|
|
Jul 26
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,898
-0.76%
|
$698,022
$39.78 P/Share
|
|
Jul 26
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
13,362
-0.94%
|
$521,118
$39.79 P/Share
|
|
Jul 14
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2
-0.0%
|
$84
$42.0 P/Share
|
|
Jul 13
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
17,832
-1.49%
|
$748,944
$42.01 P/Share
|
|
Jul 13
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
23,049
-1.53%
|
$968,058
$42.01 P/Share
|
|
Jul 12
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 12
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
100
-0.01%
|
$4,200
$42.04 P/Share
|
|
Jul 08
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
49,059
-3.08%
|
$2,060,478
$42.05 P/Share
|
|
Jul 08
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
40,655
-3.28%
|
$1,707,510
$42.05 P/Share
|
|
Jul 07
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
2,900
-0.18%
|
$121,800
$42.01 P/Share
|
|
Jul 07
2021
|
James F. Reddoch EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Indirect |
2,192
-0.18%
|
$92,064
$42.01 P/Share
|
|
Jul 06
2021
|
George W. Lloyd EVP, Investments & CLO |
SELL
Open market or private sale
|
Indirect |
36,530
-2.22%
|
$1,534,260
$42.41 P/Share
|